Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
JAMA Oncology
|
October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
Jana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E Brown, Brenda Aguilar, Renate Starr, et al.
NPJ Breast Cancer
|
June 27, 2017
Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12
Brile Chung, Ali A Esmaeili, Sailesh Gopalakrishna-Pillai, et al.
Plos One
|
February 2, 2016
Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model
Mao Ouyang, Ethan E White, Hui Ren, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 28, 2022
RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery
Shunan Liu, Yanyan Song, Ian Y Zhang, et al.
Cancer Research
|
July 23, 2014
TLR9 is critical for glioma stem cell maintenance and targeting
Andreas Herrmann, Gregory Cherryholmes, Anne Schroeder, et al.
Science Translational Medicine
|
January 20, 2017
Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
Khun Visith Keu, Timothy H Witney, Shahriar Yaghoubi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2015
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E Brown, Behnam Badie, Michael E Barish, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
May 8, 2016
Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers
Noriko Kanaya, George Somlo, Jun Wu, et al.
Science Translational Medicine
|
March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang, Renate Starr, Wen-Chung Chang, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
JAMA Oncology
|
October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
Jana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E Brown, Brenda Aguilar, Renate Starr, et al.
NPJ Breast Cancer
|
June 27, 2017
Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12
Brile Chung, Ali A Esmaeili, Sailesh Gopalakrishna-Pillai, et al.
Plos One
|
February 2, 2016
Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model
Mao Ouyang, Ethan E White, Hui Ren, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 28, 2022
RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery
Shunan Liu, Yanyan Song, Ian Y Zhang, et al.
Cancer Research
|
July 23, 2014
TLR9 is critical for glioma stem cell maintenance and targeting
Andreas Herrmann, Gregory Cherryholmes, Anne Schroeder, et al.
Science Translational Medicine
|
January 20, 2017
Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
Khun Visith Keu, Timothy H Witney, Shahriar Yaghoubi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2015
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E Brown, Behnam Badie, Michael E Barish, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
May 8, 2016
Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers
Noriko Kanaya, George Somlo, Jun Wu, et al.
Science Translational Medicine
|
March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang, Renate Starr, Wen-Chung Chang, et al.
Page
of 10